요로감염증에 대한 Norflexacin Newtam-400(r)의 효과
Efficacy of Norfloxacin (Neutam 400(r)) in Urinary Tract Infection
소속 상세정보
이상은/Lee SE
정재용/안한종/김영균/Chung JY/Ahn HJ/Kim YK
KMID : 0358319850260050507
Abstract
Forty five patients with urinary tract infection were treated with 100mg Norfloxacin twice daily for 3 or 7 days according to the seriousness of infection. Of the 19 patients with uncomplicated urinary tract infection including 5 patients with acute bacterial prostatitis or acute epididymitis, none had bacteriuria 7 days after therapy and 1 patient was reinfected 14 days after therapy discontinuation. Of the 26 patients with complicated urinary tract infection, 17 patients(65%) were uninfected 7days after therapy and among them, 3 patients were reinfected I4 days after discontinuation of therapy. Of the 9 patients with persistent infection, 4 patients had resistant bacteriuria and 5 patients had bacteriuria different from that found before therapy. Eradication rate of E. coli, Enterobacter spp., Proteus spp., Pseudomonas spp., and Serratia spp. were 100%,, 100%,, 100%,, 80% and 40%, respectively. Further clinical envaluation seems worthwhile especially in pseudomonas infections since it offers one of the very few alternatives for oral treatment of pseudomonas infections which today may require hospitalization only for the purpose of injectible antibiotics.
키워드
요로감염; 항생제; norfloxacin; urinary tract infection; neutam 400
원문 및 링크아웃 정보
등재저널 정보